TipHub

₹21.5

▼ -1 -4.44%

17 Sept 2026

NSE Listed · Trading

Medistep Healthcare Ltd. (MEDISTEP)

Volume: 0Avg Vol 1W: 16,800Avg Vol 1M: 13,22752W Range:₹16.5₹34
NSE BSE www.medistephc.com AI Report
Key Ratios
Checked just now
Market Cap₹31 Cr
Current Price₹21.5
Previous Close₹22.5
High / Low (52w)₹34 / ₹16.5
Volume0
Avg Vol (1W)16,800
Avg Vol (1M)13,227
Stock P/E5.11
Book Value₹26.62
Dividend Yield0%
ROE15.82%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin7.95%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹4.21
P/B0.81
Debt / Equity0.11
50 DMA₹20.1
200 DMA₹22.34
Day change-4.44%
Price Chart
₹21.5▼ 35.82% · 1Y
₹34₹171.4L
2025-09-17
2026-09-17

20-day avg volume: 14K shares

Pros
  • Healthy return on equity of 15.8%.
  • Company is almost debt-free.
  • Revenue grew 43% YoY.
  • Net profit is growing year over year.
  • Stock trades below its book value.
Quarterly Results
MetricJun 2024
Revenue₹11 Cr
EBITDA₹1 Cr
Net Profit₹1 Cr
EPS—
Profit & Loss (Annual)
MetricMar 2024Mar 2025Mar 2026
Revenue₹32 Cr₹50 Cr₹71 Cr
EBITDA₹4 Cr₹6 Cr₹8 Cr
Net Profit₹3 Cr₹4 Cr₹6 Cr
EPS19.964.014.68
Balance Sheet
MetricMar 2024Mar 2025Mar 2026
Total Assets₹15 Cr₹23 Cr₹50 Cr
Total Liabilities₹3 Cr₹6 Cr₹12 Cr
Equity₹12 Cr₹17 Cr₹38 Cr
Total Debt———
Cash Flow
MetricMar 2024Mar 2025Mar 2026
Operating₹-7 Cr₹0 Cr₹-18 Cr
Investing₹0 Cr₹0 Cr₹0 Cr
Financing₹7 Cr₹1 Cr₹19 Cr
Free Cash Flow₹-7 Cr₹0 Cr₹-18 Cr
Shareholding
Promoter 68.96% Institutions 0% Public 31.04%
Efficiency & Working Capital
ROCE19.2%
Interest Coverage31.7
Dividend Payout—
Debtor Days203 d
Inventory Days32 d
Payable Days19 d
Cash Conversion Cycle216 d
Working Capital Days235 d
Shareholding Details

As of 2026-03-31

Promoter69%
FII0%
DII0%
Institutions0%
Public31%
Promoter Pledge0%
No. of Shareholders514
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodDec 2024Aug 2025Aug 2025Sept 2025Mar 2026
Promoters93.6%69%69%69%69%
FIIs0%0%0%0%0%
DIIs0%0%0%0%0%
Public6.4%31%31%31%31%
Promoter Pledge0%0%0%0%0%
No. of Shareholders8525525578514
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Prajapati Hetalben ShankarlalShareholding of Promoter and Promoter Group50.1%71,16,400
Girdharilal PrajapatShareholding of Promoter and Promoter Group9.9%14,11,800
Vipul Gobarbhai DabhiShareholding of Promoter and Promoter Group8.9%12,69,880
Nitin Singh BhatiPublic Shareholding4.7%6,66,666
Vijith Narayanan MenonPublic Shareholding2.6%3,69,000
Tirulekha Biosciences Private LimitedPublic Shareholding1.9%2,76,000
Babitha MenonPublic Shareholding1.8%2,55,000
Dharmishthaben Vipulbhai DabhiShareholding of Promoter and Promoter Group0%200
Board of Directors
NameDesignationYear
Girdhari Lal PrajapatManaging Director2025
Vipul Gobarbhai DabhiExecutive Director2025
Hetalben Girdharilal PrajapatiNon Executive Director2025
Anandbhai Jitendrabhai KhodaIndependent Non Exe. Director2025
Kapilbhai Raysinhbhai DodiyaIndependent Non Exe. Director2025
Sashikala BhutraCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing segment₹13 Cr26.5%
Trading₹36 Cr73.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10151414
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000166
2025000101
2025000000
Company Information
Incorporated2023
AuditorMukesh Mishra & Associates
Investor Email[email protected]
🌐 www.medistephc.com ↗

📍 05 S.#-245/B Plot-19 T.P.S.56, Free Way Trade Center Narol, Ahmedabad, Gujarat, 382405

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Global Health LimitedMedi Assist Healthcare Services Ltd.Medicamen BiotechMedi-Caps Ltd.Medico Remedies LimitedMedicamen Organics Ltd.Medplus Health Services Ltd.Meesho LimitedMega Flex Plastics Ltd.Megastar Foods LimitedMegatherm Induction Ltd.Mangal Electrical Industries Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search